Eli Lilly and Eisai's battle to secure NHS reimbursement for their Alzheimer's disease therapies is dragging on, with guidance blocking use of the drug set for another review. After a successful ...

Tens of thousands of people living with the skin-lightening disorder vitiligo in the UK will soon be able to access an approved treatment for the first time. Reimbursement authority NICE has said that ...

NICE Ltd. engages in the provision of enterprise software solutions and services. It operates through the following segments: Customer Engagement, and Financial Crime and Compliance Solutions. The ...